SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Asensus Surgical, Inc. – ‘8-K’ for 3/11/21

On:  Friday, 3/12/21, at 4:31pm ET   ·   For:  3/11/21   ·   Accession #:  1437749-21-5934   ·   File #:  0-19437

Previous ‘8-K’:  ‘8-K’ on / for 3/3/21   ·   Next:  ‘8-K’ on 4/30/21 for 4/28/21   ·   Latest:  ‘8-K’ on 3/25/24 for 3/21/24   ·   1 Reference:  By:  Asensus Surgical, Inc. – ‘S-8’ on 7/26/21

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/12/21  Asensus Surgical, Inc.            8-K:2,9     3/11/21   13:613K                                   RDG Filings/FA

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     23K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML    212K 
 3: EX-99.2     Miscellaneous Exhibit                               HTML     46K 
 9: R1          Document And Entity Information                     HTML     48K 
11: XML         IDEA XML File -- Filing Summary                      XML     12K 
 8: XML         XBRL Instance -- transe20210311_8k_htm               XML     13K 
10: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 5: EX-101.DEF  XBRL Definitions -- asxc-20210311_def                XML     38K 
 6: EX-101.LAB  XBRL Labels -- asxc-20210311_lab                     XML     49K 
 7: EX-101.PRE  XBRL Presentations -- asxc-20210311_pre              XML     38K 
 4: EX-101.SCH  XBRL Schema -- asxc-20210311                         XSD     15K 
12: JSON        XBRL Instance as JSON Data -- MetaLinks               13±    20K 
13: ZIP         XBRL Zipped Folder -- 0001437749-21-005934-xbrl      Zip     29K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C: 
 i false  i 0000876378 0000876378 2021-03-11 2021-03-11
 


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
_________________
 
FORM  i 8-K
_________________
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
 i March 11, 2021
Date of Report (date of earliest event reported)
_________________
 
 i Asensus Surgical, Inc.
(Exact name of Registrant as specified in its charter)
_________________
 
 i Delaware
(State or other jurisdiction of
incorporation or organization)
 
 i 0-19437
(Commission
File Number)
 
 i 11-2962080
(I.R.S. Employer
Identification Number)
 
 i 1 TW Alexander Drive,  i Suite 160
 i Durham,  i NC  i 27703
(Address of principal executive offices)
 i 919- i 765-8400
(Registrants telephone number, including area code)
 
Not Applicable
(Former name or former address, if changed since last report)
_________________
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
 i  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 i  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 i  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 i  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
 
Trading symbol
 
Name of each exchange on which registered
 i Common Stock
$0.001 par value per share
 
 i ASXC
 
 i NYSE American
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company  i 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 


 
 

 
Item 2.02 Results of Operations and Financial Condition
 
On March 11, 2021, Asensus Surgical, Inc., a Delaware corporation (the “Company”), issued a press release announcing its financial results for the fourth quarter and full year ended December 31, 2020. A copy of the press release is furnished herewith as Exhibit 99.1.
 
Also on March 11, 2021, following the issuance of the press release referred to above, the Company conducted a conference call to discuss the reported operating and financial results for the fourth quarter and full year ended December 31, 2020. The Company had issued a press release on March 4, 2021 to announce the scheduling of the conference call. A copy of the transcript of the conference call is furnished herewith as Exhibit 99.2.
 
The information included herein and in Exhibit 99.1 and Exhibit 99.2 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (“Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.
 
 
Item 9.01         Financial Statements and Exhibits.
 
(d)
Exhibit
 
 
Exhibit No.
Description                                                                                    
 
 
99.1
 
 
99.2
March 11, 2021 conference call transcript
 
 
104
Cover Page Interactive Data File (formatted in inline XBRL)
 
 

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
  ASENSUS SURGICAL, INC.
   
Date: March 12, 2021 /s/ Shameze Rampertab
  Shameze Rampertab
  Executive Vice President and Chief Financial Officer
 
 

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed on:3/12/21
For Period end:3/11/2110-K
3/4/21
12/31/2010-K,  4
 List all Filings 


1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 7/26/21  Asensus Surgical, Inc.            S-8         7/26/21    3:90K                                    RDG Filings/FA
Top
Filing Submission 0001437749-21-005934   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Mar. 29, 1:23:07.1am ET